Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Physiological Control of Respiration01:23

Physiological Control of Respiration

Introduction
Breathing, a seemingly passive process, is regulated by the respiratory center in the brainstem. This center coordinates the involuntary control of respirations, which means it occurs without conscious effort, ensuring a smooth and uninterrupted pattern.
Regulation of Ventilation
The body maintains ventilation by monitoring levels of carbon dioxide (CO2), oxygen (O2), and hydrogen ion concentration (pH) in the arterial blood. Among these factors, the level of CO2 plays a crucial...
Neural Control of Respiration01:18

Neural Control of Respiration

The neural regulation of respiration is a meticulously coordinated process primarily controlled by the respiratory centers located within the brainstem. These centers, composed of specialized neurons, transmit nerve impulses that control the contraction and relaxation of our respiratory muscles.
Respiratory Centers in the Brainstem
Two primary areas comprise the respiratory center: the medullary respiratory center in the medulla oblongata and the pontine respiratory group in the pons. The...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantification of Ventilatory Control in Sleep Apnea: From Physiological Insight to Computable Loop Gain.

Sleep·2026
Same author

PMB-NN: Physiology-centered hybrid AI for personalized hemodynamic monitoring from photoplethysmography.

Computer methods and programs in biomedicine·2026
Same author

Association Between Preadmission β-Blocker Use and Venoarterial Extracorporeal Membrane Oxygenation Weaning Failure in Patients With Cardiogenic Shock.

Journal of the American Heart Association·2026
Same author

Spoilt for choice? Temporary mechanical circulatory support in cardiogenic shock: The importance of the patient.

Perfusion·2026
Same author

Exploring weaning-related shock: Cardiac injury and overload, platelet-endothelial cell activation, and inflammatory response markers following ECMO decannulation.

Perfusion·2026
Same author

Standardization of In-Vitro Evaluation of Extracorporeal Life Support (ECLS) Devices for Research and Development.

Interdisciplinary cardiovascular and thoracic surgery·2026

Related Experiment Video

Updated: May 12, 2026

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
08:49

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

9.4K

Physiological control for left ventricular assist devices based on deep reinforcement learning.

Diego Fernández-Zapico, Thijs Peirelinck1, Geert Deconinck1

  • 1Department of Electrical Engineering (ESAT), KU Leuven, Leuven, Belgium.

Artificial Organs
|September 18, 2024
PubMed
Summary
This summary is machine-generated.

This study introduces a novel deep reinforcement learning controller for left ventricular assist devices (LVADs) to improve heart failure patient outcomes. The new controller enhances aortic flow and end-diastolic volume stability compared to traditional methods.

Keywords:
cardiorespiratory simulatordeep reinforcement learningheart failureleft ventricular assist devicephysiological control

More Related Videos

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.5K
Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

1.8K

Related Experiment Videos

Last Updated: May 12, 2026

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
08:49

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

9.4K
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.5K
Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

1.8K

Area of Science:

  • Biomedical Engineering
  • Artificial Intelligence in Medicine
  • Cardiovascular Physiology

Background:

  • Heart failure (HF) poses a significant health burden, necessitating advanced Left Ventricular Assist Device (LVAD) technology.
  • Current LVAD control strategies have limitations, and reinforcement learning (RL) applications are underexplored.
  • This research focuses on improving LVAD control for better patient outcomes in severe HF.

Purpose of the Study:

  • To introduce a novel preload-based deep reinforcement learning (DRL) controller for LVADs.
  • To enhance LVAD performance by optimizing patient hemodynamics.
  • To address limitations in current LVAD control strategies using advanced AI.

Main Methods:

  • Developed a DRL controller using the proximal policy optimization algorithm.
  • Utilized a high-fidelity cardiorespiratory simulator with varied physiological parameters to model patient variability.
  • Trained the DRL controller to prevent ventricular suction and ensure aortic valve opening using critical LV pressure signals.

Main Results:

  • The DRL controller demonstrated superior end-diastolic volume (EDV) stability (5 mL SD) compared to constant speed LVAD (9 mL SD).
  • Achieved higher aortic flow rates (average 1.1 L/min) with the DRL controller versus constant speed LVAD (0.9 L/min).
  • The controller effectively managed hemodynamic parameters in a simulated severe HF population.

Conclusions:

  • A DRL-based controller was successfully implemented and validated in a sophisticated cardiorespiratory simulator.
  • The DRL controller significantly improved aortic valve flow and EDV stability over a standard constant speed LVAD.
  • This approach shows promise for advancing LVAD technology and managing heart failure.